GTCR Golder Rauner, LLC Forms Pharma Acquisition Platform, Actient Pharmaceuticals LLC; GTCR to Invest $200 Million in Actient

GTCR has formed Actient Pharmaceuticals LLC, a Deerfield, Ill.-based platform to acquire and operate specialty pharmaceutical companies and products. GTCR will invest up to $200 million in Actient, which will be run by former Abbott Labs executive Ed Fiorentino.

Back to news